Clinical Trials
7 trialsNCT01812759 2021-06-29
Fentanyl for Breakthrough Pain in the Emergency Department
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT03959852 2020-09-11
Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain
Mercy Health Ohio
Phase 4 Terminated
NCT03071744 2019-12-09
Lazanda in Cancer Patients Receiving Palliative Radiation
University of California, San Diego
Phase 2 Terminated
NCT02623959 2019-08-07
Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT01315886 2017-04-05
Conversion From Fast Acting Oral Opioids to Abstral®
Orexo AB
Phase 4 Terminated
NCT00842829 2012-10-01
Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 4 Terminated
NCT00236327 2011-05-17
Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
Janssen Cilag S.A.S.
Phase 4 Terminated